Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer

被引：0
|
作者：
Cramer, EM [1 ]
Moers, C [1 ]
Zarghooni, V [1 ]
Bosse, K [1 ]
Mallmann, P [1 ]
Warm, M [1 ]
机构：
[1] Univ Cologne, Fac Med, Cologne, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [41] A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study
    Antolin, Silvia
    Mel, Ramon
    Ramos, Manuel
    Garcia-Palomo, Andres
    Almanza, Concepcion
    de Paz, Laura
    Calvo, Lourdes
    Alvarez, Elena
    Gonzalez, Ana
    Garcia-Mata, Jesus
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (09): : 686 - 691
  • [42] Dose-dense chemotherapy in breast cancer and lymphoma
    Hudis, CA
    Schmitz, N
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (03) : 19 - 26
  • [43] Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
    Hirano, Akira
    Shimizu, Tadao
    Watanabe, Osamu
    Kinoshita, Jun
    Kimura, Kiyomi
    Kamimura, Mari
    Domoto, Kaoru
    Aiba, Motohiko
    Ogawa, Kenji
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4137 - 4142
  • [44] Phase II trial of sequential dose-dense epirubicin/cyclophosphamide (E/C) followed by docetaxel/capecitabine (D/X) as adjuvant or neoadjuvant chemotherapy for patients with HER2-negative breast cancer (BC)
    De la Cruz, S.
    Aramendia, J. M.
    Espinos, J.
    Fernandez-Hidalgo, O.
    Santisteban, M.
    Arbea, L.
    Aristu, J.
    Garran, C.
    Martinez-Monge, R.
    Martinez-Regueira, F.
    Nieto, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with breast cancer with 4 or more positive lymph nodes
    Boy, D.
    Murialdo, R.
    Angelini, I.
    Panariello, M.
    Tixi, L.
    Sacca, V.
    Piccardo, A.
    Ballestrero, A.
    [J]. BREAST, 2009, 18 : S55 - S55
  • [46] Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy
    Watanabe, Hirofumi
    Kitahara, Yoshihiro
    Murakami, Yurina
    Nihashi, Fumiya
    Matsushima, Sayomi
    Eifuku, Tatsuru
    Uto, Tomohiro
    Sato, Jun
    Imokawa, Shiro
    Suda, Takafumi
    [J]. INTERNAL MEDICINE, 2020, 59 (07) : 987 - 990
  • [47] Geparquinto: An interim safety analysis of epirubicin/cyclophosphamide followed by docetaxel with or without bevacizumab as neoadjuvant chemotherapy for primary breast cancer patients
    Von Minckwitz, G.
    Bauerfeind, I.
    Gerber, B.
    Eidtmann, H.
    Kaufmann, M.
    Costa, S. D.
    Loibl, S.
    Nekljudova, V.
    Untch, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer Improved Prognosis in Triple-Negative Tumors
    Medioni, Jacques
    Huchon, Cyrille
    Le Frere-Belda, Marie-Aude
    Hofmann, Henri
    Bats, Anne-Sophie
    Eme, Denise
    Andrieu, Jean-Marie
    Oudard, Stephane
    Lecuru, Fabrice
    Levy, Eric
    [J]. DRUGS IN R&D, 2011, 11 (02) : 147 - 157
  • [49] Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer
    Bhuvaneswari Ramaswamy
    Steven P Povoski
    Chris Rhoades
    Joan Allen
    Marsha Hauger
    Donn Young
    William Burak
    William Farrar
    Lisa Yee
    Kari Kendra
    Sivagurunathan Somasundaram
    Robert Z Orlowski
    Charles L. Shapiro
    [J]. Breast Cancer Research and Treatment, 2005, 93 : 67 - 74
  • [50] Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer
    Ramaswamy, B
    Povoski, SP
    Rhoades, C
    Allen, J
    Hauger, M
    Young, D
    Burak, W
    Farrar, W
    Yee, L
    Kendra, K
    Somasundaram, S
    Orlowski, RZ
    Shapiro, CL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (01) : 67 - 74
12345